A 24-week study to evaluate the effectiveness of valsartan in combination with hydrochlorothiazide versus amlodipine on arterial compliance in patients with hypertension, type 2 diabetes and albuminuria

Trial Profile

A 24-week study to evaluate the effectiveness of valsartan in combination with hydrochlorothiazide versus amlodipine on arterial compliance in patients with hypertension, type 2 diabetes and albuminuria

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Amlodipine; Valsartan/hydrochlorothiazide
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 07 Nov 2011 Actual patient number is 144 according to ClinicalTrials.gov.
    • 07 Nov 2011 Actual end date (September 2006) added as reported by ClinicalTrials.gov.
    • 08 Jan 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top